‹³ˆõî•ñ
Ž–¼ “c’†@_Šö
ƒtƒŠƒKƒi ƒ^ƒiƒJ@ƒqƒƒL
E–¼ “Á”C•‹³
ŠwˆÊ –ò‰ÈŠw
Œ¤‹†Žº –ò•¨Šw
“d˜b”ԍ† 043-226-2894
ƒ[ƒ‹ƒAƒhƒŒƒX hiroki_tanaka8922—chiba-u.jp@i—‚Í‘SŠp•\‹Lj
’S“–u‹` —Տ°–ò•¨“®‘ÔŠw
ê–啪–ì –ò•¨‘—’BŠw
Œ¤‹†ƒe[ƒ} Ž‰Ž¿ƒiƒm—±Žqƒhƒ‰ƒbƒOƒfƒŠƒoƒŠ[ƒVƒXƒeƒ€
Žå‚ÈŒ¤‹†‹ÆÑ

Tanaka Hiroki, Oasa Sho, Kinjo Masataka, Nakai Yuta, Harashima Hideyoshi, Akita Hidetaka. gTemperature and pH sensitivity of stabilized self-nanoemulsion formed using an ionizable lipid-like material via an oil-to-surfactant transition.h. Colloids and Surfaces B: Biointerfaces. Elsevier. 151: 95-101. 2017.

Watanabe Ayaka, Tanaka Hiroki (equally contributed), Sakurai Yu. Ohkawara Tatsuya, Takeda Hiroshi, Harashima Hideyoshi, Akita Hidetaka. gEffect of particle size on their accumulation in an inflammatory lesion in a detran sulfate sodium (DSS)-induced colitis model.h. International Journal of Pharmaceutics. Elsevier. 509:118-122. 2016.

Tanaka Hiroki, Akita Hidetaka, Ishiba Ryohei, Tange Kota, Arai Masaya, Kubo Kazuhiro, Harashima Hideyoshi. gNeutral biodegradable lipid-envelope-type nanoparticle using vitamin A-Scaffold for nuclear targeting of plasmid DNA.h. Biomaterials. Elsevier. 35:1755-1761. 2014.

Akita Hidetaka, Ryohei Ishiba, Hatakeyama Hiroto, Tanaka Hiroki, Sato Yusuke, Tange Kota, Arai Masaya, Kubo Kazuhiro, Harashima Hideyoshi. gA Neutral Envelope-Type Nanoparticle Containing pH Responsive and SS-Cleavable Lipid-Like Material as a Carrier for Plasmid DNA.h. Advanced Healthcare Materials, Wiley-VCH. 2:1120-1125. 2013.

Akita Hidetaka, Enoto Kaoru, Tanaka Hiroki, Harashima Hideyoshi. gParticle tracking analysis for the intracellular trafficking of nanoparticles modified with African swine fever virus protein p54-derived peptide.h. Molecular Therapy, Nature Publishing Group. 21:309-317. 2013.


Š‘®Šw‰ï “ú–{–òŠw‰ï
“ú–{–òÜŠw‰ï
“ú–{DDSŠw‰ï
ŠwŠO‚Å‚Ì‹³ˆçEŒ¤‹†Šˆ“®